Overall rank by patents
#23,854
of 50,000 tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 12 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H01M (PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY).
The verdict
According to USPTO PatentsView, Ampcera ranks #23,854 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 12 technology areas.
USPTO PatentsView assignee plate
Corpus R23854 · US Corporation #23,854 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Alvarion Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Ampcera · this assignee
52 score
3D Lighting Innovati… · lowest
7 score
What this shows Ampcera's Innovation Score is 52.1/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Ampcera Inc. is a focused PatentsView assignee: 12 CPC subclasses with 100% of grants classified under H01M (PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY). Peak complete grant year is 2024 (5 grants) versus a trough of 1 in 2021. By volume, Ampcera sits between Alvarion Ltd. and Ansun Biopharma, Inc..
Ampcera Inc. shows 8 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Alvarion Ltd.
11 patents
American Woodmark Management Company
11 patents
Amina Technologies Limited
11 patents
AmpThink, LLC
11 patents
Amplidata N.V.
11 patents
Angel Armor, LLC
11 patents
Anhui Huami Health Technology Co., Ltd.
11 patents
Ansun Biopharma, Inc.
11 patents
Ampcera Inc.
11 patents
What this shows Ampcera holds 11 patents at rank #23,908, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #23,908 in granted patent volume.
Other assignees with the most granted patents in Ampcera's primary technology class.
Ampcera's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
52 Top 11% higher than 89% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 9.1% |
| 2023 | 3 | 27.3% |
| 2024 | 5 | 45.5% |
| 2025partial year | 2 | 18.2% |
Top 12 of 12 technology areas
Overall rank by patents
#23,854
of 50,000 tracked assignees
52.1 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.